Use of Cholinesterase Inhibitors in Non-Alzheimer’s Dementias

Dementia with Lewy bodies: an update and outlook

(2019) Tiago Fleming Outeiro et al.   Molecular Neurodegeneration

Neurotransmitter deficits from frontotemporal lobar degeneration

(2018) Alexander G Murley et al.   BRAIN

Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV

(2018) Siamak Nejad-Davarani et al.   MOLECULAR PSYCHIATRY

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta‑analysis

(2018) Yan‑Hong Meng et al.   Experimental and Therapeutic Medicine

Cognitive decline in Parkinson disease

(2017) Dag Aarsland et al.   Nature Reviews Neurology

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy

(2017) Hiroaki Kazui et al.   PSYCHIATRY RESEARCH

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia

(2017) Qing Liu et al.   Frontiers in Aging Neuroscience

Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials

(2016) Etsuro Mori et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cholinergic imaging in dementia spectrum disorders

(2016) Roman Roy et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Update on Vascular Dementia

(2016) Ayesha Khan et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial

(2016) Etsuro Mori et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonists

(2015) S. Sakura Minami et al.   BIOCHEMICAL PHARMACOLOGY

Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies

(2015) Etsuro Mori et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Frontotemporal dementia

(2015) Jee Bang et al.   LANCET

Vascular dementia

(2015) John T O'Brien et al.   LANCET

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

(2015) Manabu Ikeda et al.   Alzheimers Research & Therapy

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

(2015) Etsuro Mori et al.   Alzheimers Research & Therapy

Long-term Safety of Rivastigmine in Parkinson Disease Dementia

(2014) Murat Emre et al.   CLINICAL NEUROPHARMACOLOGY

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

(2014) H.-F. Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies

(2014) Katsuyuki Ukai et al.   Psychogeriatrics

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

(2013) Manabu Ikeda et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Donepezil-Induced Confusional State in a Patient With Autopsy-Proven Behavioral-Variant Frontotemporal Dementia

(2013) David B. Arciniegas et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial

(2012) Etsuro Mori et al.   ANNALS OF NEUROLOGY

Cholinergic Deficit and Response to Donepezil Therapy in Parkinson’s Disease with Dementia

(2012) Kotaro Hiraoka et al.   EUROPEAN NEUROLOGY

Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study

(2012) Bruno Dubois et al.   MOVEMENT DISORDERS

Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders

(2012) Vikas Kotagal et al.   NEUROSCIENCE LETTERS

Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report

(2012) Asami OZAKI et al.   Psychogeriatrics

Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia

(2011) Daniel Weintraub et al.   American Journal of Alzheimers Disease and Other Dementias

Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder

(2011) B. N. Dugger et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

The history of the cholinergic hypothesis

(2010) Antonio Contestabile   BEHAVIOURAL BRAIN RESEARCH

Improved Visual Hallucination by Donepezil and Occipital Glucose Metabolism in Dementia with Lewy Bodies: The Osaki-Tajiri Project

(2010) Masayuki Satoh et al.   EUROPEAN NEUROLOGY

Efficacy of low-dose donepezil for visual hallucinations in a patient with dementia with Lewy bodies

(2010) Yasutaka Fujita et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia

(2010) Gustavo C. Román et al.   STROKE

Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment

(2009) Juan Wang et al.   ACTA PHARMACOLOGICA SINICA

A Multicenter, Open-Label, 24-Week Follow-Up Study for Efficacy on Cognitive Function of Donepezil in Binswanger-Type Subcortical Vascular Dementia

(2009) Jay Cheol Kwon et al.   American Journal of Alzheimers Disease and Other Dementias

Choline Acetyltransferase Activity in Vascular Dementia and Stroke

(2009) Sally I. Sharp et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia

(2009) Wolfgang Oertel et al.   DRUG SAFETY

The long-term efficacy and tolerability of donepezil in patients with vascular dementia

(2009) David Wilkinson et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Cholinergic deficiency in Alzheimer's and Parkinson's disease: Evaluation with pupillometry

(2009) D.F. Fotiou et al.   INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY

Different Responses to Rivastigmine in Subcortical Vascular Dementia and Multi-Infarct Dementia

(2008) Rita Moretti et al.   American Journal of Alzheimers Disease and Other Dementias

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study

(2008) C. Ballard et al.   CURRENT MEDICAL RESEARCH AND OPINION

Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia

(2008) A. Kertesz et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations

(2008) John T. O’Brien et al.   NEUROIMAGE